Born with a Plastic Spoon in Their Mouth? - Substitution, Interchangeability, and Marketing of Biosimilars.
- Publication Type:
- Journal Article
- Citation:
- J Law Med, 2022, 29, (1), pp. 208-223
- Issue Date:
- 2022-03
In Progress
Filename | Description | Size | |||
---|---|---|---|---|---|
(2022) 29 Journal of Law and Medicine 208.pdf | 132.72 kB |
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is being processed and is not currently available.
Biosimilar medicines have the potential to increase medicine access and bring cost savings to consumers, but uptake has been slow for a range of reasons. This article analyses one such reason, namely the potential for competitors' promotional materials to use certain terms with technical meanings, such as "interchangeable" and "substitution", in a misleading way. Against the backdrop of a flawed co-regulatory system for pharmaceutical marketing, the article identifies a need for clear regulatory statements about appropriate uses of such terms in pharmaceutical marketing and promotion.
Please use this identifier to cite or link to this item: